Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANQUIT: Varenicline vs NRT for Smoking Cessation in HIV+ Patients
NCT01800019Phase 3Unknown
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Jan 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline in Tobacco Use Disorder (TUD), sponsored by Ottawa Hospital Research Institute. Status: unknown.
02
Drugs
varenicline
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT01800019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01800019.